Millennium Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RLMD
JHC
Millennium Management's RLMD Position: Q3 2026 in Review
Millennium Management increased its Relmada Therapeutics (RLMD) stake by 42% in Q3 2026, buying an estimated $4.83M and bringing the position to 3,345,573 shares worth $12.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2064.
Millennium Management first reported a position in RLMD in Q4 2019 and has held it in 23 quarters since. The position peaked at $27.2M in Q1 2026. 134 funds tracked by Wall St. Rank hold RLMD as of Q3 2026.
- Millennium Management held 3,345,573 shares of Relmada Therapeutics worth $12.6M as of Q3 2026.
- Millennium Management bought 983,746 Relmada Therapeutics shares in Q3 2026, an estimated $4.83M.
- Relmada Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #2064 holding.
- Millennium Management first reported a position in Relmada Therapeutics in Q4 2019 and has held it in 23 quarters since.
- Millennium Management's Relmada Therapeutics position peaked at $27.2M in Q1 2026.
- 134 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.